DWOAX
Price
$21.01
Change
+$0.21 (+1.01%)
Updated
Sep 15 closing price
Net Assets
1.71B
GFFFX
Price
$88.10
Change
+$0.62 (+0.71%)
Updated
Sep 15 closing price
Net Assets
337.84B
Interact to see
Advertisement

DWOAX vs GFFFX

Header iconDWOAX vs GFFFX Comparison
Open Charts DWOAX vs GFFFXBanner chart's image
BNY Mellon Research Growth A
Price$21.01
Change+$0.21 (+1.01%)
VolumeN/A
Net Assets1.71B
American Funds Growth Fund of Amer F2
Price$88.10
Change+$0.62 (+0.71%)
VolumeN/A
Net Assets337.84B
DWOAX vs GFFFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DWOAX vs. GFFFX commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DWOAX is a StrongBuy and GFFFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFFFX has more cash in the bank: 338B vs. DWOAX (1.71B). GFFFX pays higher dividends than DWOAX: GFFFX (0.51) vs DWOAX (0.00). DWOAX was incepted earlier than GFFFX: DWOAX (17 years) vs GFFFX (17 years). DWOAX (1.09) is less costly to investors than GFFFX (0.40). DWOAX is a more actively managed with annual turnover of: 27.94 vs. GFFFX (25.00). GFFFX has a lower initial minimum investment than DWOAX: GFFFX (250) vs DWOAX (1000). GFFFX annual gain was more profitable for investors over the last year : 17.20 vs. DWOAX (10.52). GFFFX return over 5 years is better than : 46.95 vs. DWOAX (10.64).
DWOAXGFFFXDWOAX / GFFFX
Total Expense Ratio1.000.40250%
Annual Report Gross Expense Ratio1.090.40273%
Fund Existence17 years17 years-
Gain YTD4.47017.94525%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.71B338B1%
Annual Yield % from dividends0.000.51-
Returns for 1 year10.5217.2061%
Returns for 3 years62.8862.88100%
Returns for 5 years10.6446.9523%
Returns for 10 years48.83105.1046%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENTO3.590.44
+13.97%
Entero Therapeutics Inc
OVID1.280.02
+1.59%
Ovid Therapeutics
PHIN57.49-0.71
-1.22%
PHINIA
ICLR170.46-4.54
-2.59%
ICON plc
SUPV5.36-0.17
-3.07%
Grupo Supervielle SA